Labcorp reported $14.3B of revenue over the trailing twelve months, +6.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $14.3B (to Q2 2026). Net income: $1.00B, trailing twelve months to Q2 2026. Free cash flow: $1.16B, trailing twelve months to Q2 2026. Operating margin: 10%, trailing twelve months to Q2 2026.

LHLabcorp

Healthcare

$312.23+14% 1Y

$312.23

$244.6952 weeks$339.57

LH as reported

Labcorp reported $14.3B of revenue over the trailing twelve months, +6.4% on the year before. 11 reported series are charted on this page, each one as filed.

$14.3B

Revenue, trailing twelve months · to Q2 2026 · +6.4% against the twelve months before

Net income: $1.00B
Net income · +31% year on year · trailing twelve months to Q2 2026
Free cash flow: $1.16B
Free cash flow · −8.4% year on year · trailing twelve months to Q2 2026
Operating margin: 10%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for LH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$14.3B	+6.4%	Q2 2026
Net income	$1.00B	+31%	Q2 2026
EPS	$12.09	+33%	Q2 2026
Gross margin	29%	n/a	Q2 2026
Operating margin	10%	n/a	Q2 2026
Net margin	7.0%	n/a	Q2 2026
ROE	11%	n/a	Q2 2026
ROA	4.9%	n/a	Q2 2026
ROIC	8.1%	n/a	Q2 2026
Free cash flow	$1.16B	−8.4%	Q2 2026
P/E	25.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.